MediWound Ltd (MDWD)

3.72 +0.07  +1.92% NASDAQ Oct 19, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/13/2020 08:30 EST Misc MediWound Ltd Third Quarter Earnings Conference Call for 2020
11/13/2020 Earnings MediWound Ltd Third Quarter Earnings for 2020 Release
08/06/2020 08:30 EDT Misc MediWound Ltd Second Quarter Earnings Conference Call for 2020
08/06/2020 07:00 EDT Earnings MediWound Ltd Second Quarter Earnings Results for 2020
06/29/2020 09:30 CDT Misc MediWound Ltd Annual General Meeting for 2019
05/20/2020 08:30 EDT Misc MediWound Ltd First Quarter Earnings Conference Call for 2020
05/20/2020 07:00 EDT Earnings MediWound Ltd First Quarter Earnings Results for 2020
02/25/2020 08:30 EST Misc MediWound Ltd Fourth Quarter Earnings Conference Call for 2019
02/25/2020 07:00 EST Earnings MediWound Ltd Fourth Quarter Earnings Results for 2019
02/25/2020 Misc MediWound Ltd Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.mediwound.com
  • Investor Relations URL: http://ir.mediwound.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 13, 2020
  • Last Earnings Release: Aug. 06, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. Its first biopharmaceutical product, NexoBrid removes dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns, also referred to as severe burns. NexoBrid is currently in clinical development in North America and is in the process of preparing its Biologics License Application. The company derives its revenue from United States.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.